A vs ALLO: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Allogene Therapeutics Inc in 2026
A
Agilent Technologies Inc
$114.42
ALLO
Allogene Therapeutics Inc
$2.32
Key Metrics Comparison
| Metric | A | ALLO | Winner |
|---|---|---|---|
| Market Cap | $32.34B | $832.43M | A |
| P/E Ratio | 25.26 | N/A | A |
| EPS (TTM) | $4.53 | $N/A | A |
| Revenue Growth | 0.1% | -1.0% | A |
| Gross Margin | 52.3% | 0.0% | A |
Analyze A
Full quant analysis
Analyze ALLO
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ALLO a better investment?
Comparing A and ALLO: Agilent Technologies Inc has a market cap of $32.34B while Allogene Therapeutics Inc has $832.43M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ALLO?
A (Agilent Technologies Inc) and ALLO (Allogene Therapeutics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ALLO?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ALLO?
A has higher revenue growth at 0.1% vs -1.0% for ALLO.
Which company is more profitable: A or ALLO?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 0.0% for ALLO.
Which is the larger company: A or ALLO?
Agilent Technologies Inc (A) is larger with a market cap of $32.34B compared to $832.43M for ALLO.
Should I buy A or ALLO in 2026?
Both A and ALLO have investment merit. A trades at $114.42 while ALLO trades at $2.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ALLO stock?
Key differences: Market Cap ($32.34B vs $832.43M), P/E Ratio (25.3x vs N/A), Revenue Growth (0.1% vs -1.0%), Gross Margin (52.3% vs 0.0%).